Evaluation of NIAID's HIV Vaccine Research Education Initiative Highly Impacted Population Survey

Forms and Documents

Document Name	Status
Form 1 Screeners and Survey Questionnaire Form and Instruction	New
OMBSectionBHIP_Final11_18_09.doc Supporting Statement B	2009-11-20
Attachment F_GeoDiversity of Panel.pdf Supplementary Document	2009-11-20
Attachment E_KN_CPS Comparison .pdf Supplementary Document	2009-11-20
Attachment B_IRB Approval LetterEBNG.pdf Supplementary Document	2009-11-20
Attachment A_Privacy Act-Pla'0001.pdf Supplementary Document	2009-11-20
OMB_Section_AHIPFinal11_20_09.doc Supporting Statement A	2009-11-20

IC Document Collections

IC ID	Document Title	Status
191539	Screeners and Survey Questionnaire Form and Instruction	New

ICR Details

OMB Control No: 0925-0618	ICR Reference No: 200912-0925-002
Status: Historical Inactive	Previous ICR Reference No:
Agency/Subagency: HHS/NIH	Agency Tracking No:
Title: Evaluation of NIAID's HIV Vaccine Research Education Initiative Highly Impacted Population Survey
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Withdrawn	Conclusion Date: 04/21/2010
	Date Received in OIRA: 12/11/2009
Terms of Clearance: ICR is withdrawn per an email from NIH on 4/21/2010. A 30-day notice does not need to be republished before the package is resubmitted if the only changes made are those discussed during OMB review.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date		36 Months From Approved
Responses	0	0	0
Time Burden (Hours)	0	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: This survey is the third component of an evaluation of NHVREI. This component will provide population estimates for the general and highly impacted populations (African American, Hispanic/Latino, and men who have sex with men [MSM]) regarding the proportion of individuals reporting awareness, knowledge, and attitudes supportive of the development of methods for preventing HIV (i.e., vaccine, microbicides, and PrEP). In addition, the survey will identify concerns that deter participation in clinical trials as well as other negative attitude patterns that can be targeted by future educational efforts. Information obtained will be used to guide future programs designed to improve support for the development of HIV preventive measures.

---

Authorizing Statute(s): US Code: 42 USC 285f Name of Law: National Institute of Allergy and Infectious Diseases
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	74 FR 44855	08/31/2009
30-day Notice:	Federal Register Citation:	Citation Date:
	74 FR 65778	12/11/2009
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Screeners and Survey Questionnaire	1	Survey

---

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new ICR.

---

Annual Cost to Federal Government: $336,666

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/11/2009

---